1. Home
  2. HLIO vs ADMA Comparison

HLIO vs ADMA Comparison

Compare HLIO & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HLIO

Helios Technologies Inc.

SELL

Current Price

$68.51

Market Cap

2.3B

Sector

Industrials

ML Signal

SELL

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$10.30

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIO
ADMA
Founded
1970
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
HLIO
ADMA
Price
$68.51
$10.30
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
★ $94.67
$17.00
AVG Volume (30 Days)
350.8K
★ 3.1M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 0.70%
N/A
EPS Growth
★ 23.93
N/A
EPS
★ 1.25
0.35
Revenue
★ $200,727,000.00
$42,219,783.00
Revenue This Year
$6.91
$4.93
Revenue Next Year
$5.86
$17.59
P/E Ratio
$55.10
★ $29.14
Revenue Growth
N/A
★ 43.85
52 Week Low
$49.00
$7.21
52 Week High
$95.05
$20.46

Technical Indicators

Market Signals
Indicator
HLIO
ADMA
Relative Strength Index (RSI) 44.45 60.38
Support Level $66.25 $9.23
Resistance Level $69.41 $11.42
Average True Range (ATR) 1.78 0.39
MACD 0.25 0.04
Stochastic Oscillator 27.77 81.96

Price Performance

Historical Comparison
HLIO
ADMA

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: